Phase III study comparing cyclophosphamide, doxorubicin, and etoposide (CDE) to carboplatin and paclitaxel (CP) in patients (pts) with extensive disease small cell lung cancer (ED SCLC).

7045 Background: CP has shown activity in CDE resistant pts with ED SCLC (Groen JCO 1999). We performed a RCT comparing CDE and CP in chemonaive pts with ED SCLC. Methods: Primary end point: progre...